(19)
(11) EP 1 181 055 A2

(12)

(88) Date of publication A3:
31.05.2001

(43) Date of publication:
27.02.2002 Bulletin 2002/09

(21) Application number: 00923446.9

(22) Date of filing: 17.04.2000
(51) International Patent Classification (IPC)7A61K 47/48
(86) International application number:
PCT/US0010/327
(87) International publication number:
WO 0069/472 (23.11.2000 Gazette 2000/47)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 14.05.1999 US 134135 P

(71) Applicant: BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Ridgefield, Connecticut 06877-0368 (US)

(72) Inventors:
  • FIRESTONE, Raymond, A.
    Stamford, CT 06902 (US)
  • TELAN, Leila, A.
    Somerville, MA 02143 (US)

(74) Representative: Laudien, Dieter, Dr. 
Boehringer Ingelheim GmbH Abteilung Patente
55216 Ingelheim
55216 Ingelheim (DE)

   


(54) ENZYME-ACTIVATED ANTI-TUMOR PRODRUG COMPOUNDS